To explore how the JNK inhibitor affects Ph+ B-ALL cells, we treated the SUP-B15 cells with JNK-IN-8 and examined the expression of anti-apoptotic proteins MCL-1, BCL-XL, and BCL-2, as well as c-MYC. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.